Advertisement
News
Subscribe to MDT Magazine News

CMC Biologics Announces Appointment of New CEO

May 2, 2011 11:35 am | by Bio-Medicine.Org | Comments

COPENHAGEN, Denmark and SEATTLE, May 2, 2011 /- CMC Biologics, a leading biopharmaceutical Contract Manufacturing Organization, with operations in Copenhagen, Denmark and Seattle, Washington USA, announced today that it has hired Claes Glassell to serve at its Chief Executive Officer. CMC...

TOPICS:

Hill-Rom to Participate in the Bank of America Merrill Lynch Health Care Conference

May 2, 2011 11:35 am | by Bio-Medicine.Org | Comments

BATESVILLE, Ind., May 2, 2011 /- Hill-Rom Holdings, Inc., (NYSE: HRC ) invites you to listen to a management presentation at the Bank of America Merrill Lynch Health Care Conference in Las Vegas on May 10, 2011, at 2:20 p.m. EDT. You are invited to listen to the live discussion via the...

TOPICS:

Summary Box: Community Health raises Tenet offer

May 2, 2011 10:45 am | by The Associated Press | Comments

HIGHER BID: Community Health Systems Inc. said Monday it raised its offer to buy rival hospital operator Tenet Healthcare Corp. to $7.25 per share, which increases the deal's value by 21 percent to about $4.06 billion. But it said the all-cash offer expires May 9 unless it sees meaningful...

Advertisement

Ariad Pharmaceuticals shuffles board members

May 2, 2011 10:36 am | by Mass High Tech: The Journal of New England Technology | Comments

Ariad Pharmaceuticals has appointed Norbert G. Riedel to its board of directors. Riedel currently serves as corporate vice president and chief scientific officer of health care company Baxter International Inc. in Deerfield, Ill.

TOPICS:

Yale to work with Icagen, Pfizer on novel pain treatments

May 2, 2011 10:35 am | by Mass High Tech: The Journal of New England Technology | Comments

The Yale School of Medicine in New Haven, Conn., said it will collaborate with Icagen Inc. and Pfizer to explore the potential efficacy of investigational compounds as novel treatments for a rare genetic disorder called inherited erythromelalgia.

AstraZeneca declines license for Targacept drug

May 2, 2011 9:45 am | by The Associated Press | Comments

Targacept Inc. said Monday that British drugmaker AstraZeneca will not exercise its option to license a potential schizophrenia drug.The drug, called TC-5619, failed in a midstage, proof-of-concept study in March focusing on non-smokers with attention-deficit/attention hyperactivity disorder....

STEM Savvy High School Students Connect with Industry

May 2, 2011 9:38 am | by Society of Manufacturing Engineers | Comments

DEARBORN, Mich., LYNNWOOD, Wash., April 29, 2011 — Tech-savvy teams from various high schools located in Washington's Snohomish and the Island County regions will present their STEM-based projects to local manufacturers—potential employers, who are in desperate need of skilled...

NMT Medical, Inc. Assigned All Its Assets to Joseph F. Finn, Jr., C.P.A. of the Firm Finn, Warnke & Gayton, LLP on April 20, 2011

May 2, 2011 9:33 am | by Bio-Medicine.Org | Comments

WELLESLEY HILLS, Mass., May 2, 2011 /- On April 20, 2011, NMT Medical, Inc. ("NMT Medical") assigned all its assets to Joseph F. Finn, Jr., C.P.A. ("Finn") of the firm Finn, Warnke & Gayton, LLP to be liquidated for the benefit of NMT Medical creditors. NMT Medical's intellectual...

TOPICS:
Advertisement

Generex Biotechnology Corporation CEO to Present Live, Online at RetailInvestorConferences.com on May 5th

May 2, 2011 9:33 am | by Bio-Medicine.Org | Comments

NEW YORK, May 2, 2011 /- Generex Biotechnology Corporation ( www.generex.com ) (OTC: GNBT) today announced that Mark Fletcher, CEO, will present at RetailInvestorConferences.com. DATE: May 5th, 2011 TIME:  11:00 AM EDT LINK: www.retailinvestorconferences.com >Click the red...

TOPICS:

Perrigo Announces FDA Final Approval for Minoxidil Foam - Generic Equivalent to Men's Rogaine® Foam

May 2, 2011 9:32 am | by Bio-Medicine.Org | Comments

ALLEGAN, Mich., May 2, 2011 /- Perrigo Company (Nasdaq: PRGO ; TASE) today announced that it has received final approval from the U.S. Food and Drug Administration for its abbreviated new drug application for over-the-counter (OTC) Minoxidil Foam, a generic version of Men's Rogaine®...

TOPICS:

Community Health raises all-cash offer for Tenet

May 2, 2011 8:45 am | by TOM MURPHY - AP Business Writer - Associated Press | Comments

Community Health Systems Inc. has raised its offer for rival hospital operator Tenet Healthcare Corp. by 21 percent to about $4.06 billion, but it said Monday the latest bid may only last a week. Analysts said they doubt a deal will happen.Shares of both companies fell in midday trading.The...

Michigan Growth Capital Symposium Unveils Robust Line Up of Presenting Companies for 30th Anniversary Event

May 2, 2011 8:35 am | by Bio-Medicine.Org | Comments

ANN ARBOR, Mich., May 2, 2011 /- Anticipating record attendance among the investment community at the upcoming Michigan Growth Capital Symposium , taking place May 10-11 at the Marriott Resort in Ypsilanti, Mich., event organizers today unveiled the complete list of companies that will...

TOPICS:

Prexa names Graham, Reines to executive staff

May 2, 2011 8:34 am | by Mass High Tech: The Journal of New England Technology | Comments

Prexa Pharmaceuticals Inc., a Boston biotech focused on developments to treat central nervous system disorders, has appointed Evelyn Graham as chief operating officer and Scott Reines as chief medical officer.

TOPICS:

Aoxing Pharmaceutical Company Announces Issuance of Chinese Patent for Naloxone Sublingual Film

May 2, 2011 8:34 am | by Bio-Medicine.Org | Comments

JERSEY CITY, N.J., May 2, 2011 /- Aoxing Pharmaceutical (NYSE Amex: AXN ) ("Aoxing Pharma"), a specialty pharmaceutical company focusing on research, development, manufacturing and distribution of narcotic and pain-management products, announced that its operating subsidiary in China,...

TOPICS:

SeraCare Life Sciences Announces Renewal of National Institutes of Health Contract to Support Research

May 2, 2011 8:34 am | by Bio-Medicine.Org | Comments

MILFORD, Mass., May 2, 2011 /- SeraCare Life Sciences announced today that the National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health has awarded a new contract to SeraCare, replacing the current contract which expired on April 30, 2011. Under this...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading